Prognosis Value of Residual Disease Monitoring by Polymerase Chain Reaction in Patients With CBFβ/MYH11-Positive Acute Myeloblastic Leukemia
Open Access
- 15 March 1997
- journal article
- Published by American Society of Hematology in Blood
- Vol. 89 (6) , 2222
- https://doi.org/10.1182/blood.v89.6.2222
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical relevance of residual disease monitoring by polymerase chain reaction in patients with ALL‐1/AF‐4 positive‐acute lymphoblastic leukaemiaBritish Journal of Haematology, 1996
- Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remissionBritish Journal of Haematology, 1995
- Philadelphia chromosome‐negative chronic myeloid leukaemia: a report of 14 new casesBritish Journal of Haematology, 1995
- Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia [see comments]Blood, 1995
- Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemiasBlood, 1995
- Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplificationBlood, 1994
- Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemiaBlood, 1994